Goldman Sach Cuts Price Target on Medicis (MRX)
Tweet Send to a FriendGet Alerts MRX Hot Sheet
Price: $43.98 --0%
Rating Summary:
6 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
6 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade MRX Now!
Goldman Sachs maintained a Buy rating on Medicis (NYSE: MRX) but lowered their price target to $42.00 (from $45.00) due to higher execution risk.
"We expect some pressure on the shares given increased execution risk, but maintain our Buy rating with the view that the overall growth story is still intact and the shares already reflected some of these concerns. We also see support from significant cash flow generation, a strong balance sheet, and meaningful M&A potential," said analyst Gregory Waterman.
For an analyst ratings summary and ratings history on Medicis click here. For more ratings news on Medicis click here.
Shares of Medicis closed at $33.31 yesterday, with a 52 week range of $29.76-$40.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"We expect some pressure on the shares given increased execution risk, but maintain our Buy rating with the view that the overall growth story is still intact and the shares already reflected some of these concerns. We also see support from significant cash flow generation, a strong balance sheet, and meaningful M&A potential," said analyst Gregory Waterman.
For an analyst ratings summary and ratings history on Medicis click here. For more ratings news on Medicis click here.
Shares of Medicis closed at $33.31 yesterday, with a 52 week range of $29.76-$40.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Workday (WDAY) Success Continues but Valuation Lofty, Goldman Maintains Neutral
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
- Deutsche Bank Raises PT on NetApp (NTAP) to $48
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Goldman Sachs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
